InnoPharmax Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	185.79	97.28	166.73	39.36	40.53	90.51
Short-Term Investments	77.98	49	114.5	100.3	55.85	96.76
Cash & Short-Term Investments	263.77	146.28	281.23	139.66	96.37	187.26
Cash Growth	8.30%	-47.98%	101.37%	44.91%	-48.54%	-22.58%
Accounts Receivable	6.85	1.83	4.53	6.96	-	-
Other Receivables	0.64	0.89	0.47	0.82	0.57	4.03
Receivables	7.49	2.72	5	7.78	0.57	4.03
Inventory	7.9	15.12	18.34	25.53	30.5	16.12
Prepaid Expenses	4.41	2.8	2.46	3.38	1.1	1.92
Other Current Assets	-	8.58	13.26	12.65	8.2	-
Total Current Assets	283.57	175.51	320.29	188.99	136.74	209.33
Property, Plant & Equipment	14.35	3.42	8.59	13.77	19.57	13.77
Long-Term Investments	245.08	251.32	261.21	269.14	278.43	283.97
Other Intangible Assets	4.9	5.27	6.22	6.72	8.85	9.75
Long-Term Accounts Receivable	-	-	-	6.09	6.09	6.09
Long-Term Deferred Tax Assets	15.89	15.89	19.4	21.72	21.72	21.72
Other Long-Term Assets	17.55	17.58	17.35	17.75	17.92	11.53
Total Assets	581.33	468.98	633.06	524.2	489.31	556.16
Accounts Payable	8.32	9.57	2.4	6.7	0.84	0.84
Accrued Expenses	-	24.07	8.57	0	0.23	0.04
Short-Term Debt	-	10	10	11.5	23.27	-
Current Portion of Leases	4.36	0.82	4.57	4.48	4.42	4.5
Current Unearned Revenue	2.7	3.64	2.44	0.18	0.18	0.18
Other Current Liabilities	28.8	1.71	1.41	11.09	10.19	8.66
Total Current Liabilities	44.18	49.81	29.4	33.95	39.13	14.22
Long-Term Leases	7.44	-	0.82	5.39	9.86	1.08
Other Long-Term Liabilities	-	-	-	9.32	9.32	9.32
Total Liabilities	51.61	49.81	30.22	48.65	58.31	24.61
Common Stock	1,196	1,076	1,076	949.97	868.36	867.19
Additional Paid-In Capital	160.43	100.43	100.43	34.17	0.77	52.86
Retained Earnings	-826.47	-757.01	-572.96	-507.84	-437.48	-386.89
Comprehensive Income & Other	-	-	-0.44	-0.75	-0.66	-1.61
Shareholders' Equity	529.72	419.18	602.85	475.55	431	531.54
Total Liabilities & Equity	581.33	468.98	633.06	524.2	489.31	556.16
Total Debt	11.8	10.82	15.39	21.36	37.56	5.57
Net Cash (Debt)	251.98	135.46	265.84	118.29	58.82	181.69
Net Cash Growth	12.51%	-49.04%	124.73%	101.12%	-67.63%	-14.29%
Net Cash Per Share	2.25	1.26	2.73	1.28	0.68	2.10
Filing Date Shares Outstanding	115.76	107.58	107.58	95	86.84	86.72
Total Common Shares Outstanding	115.76	107.58	107.58	95	86.84	86.72
Working Capital	239.39	125.7	290.89	155.05	97.61	195.11
Book Value Per Share	4.58	3.90	5.60	5.01	4.96	6.13
Tangible Book Value	524.82	413.91	596.62	468.82	422.15	521.8
Tangible Book Value Per Share	4.53	3.85	5.55	4.94	4.86	6.02
Machinery	-	35.94	35.67	35.14	34.74	36.97
Leasehold Improvements	-	0.66	0.66	0.66	0.66	0.66